We also classified signatures into four categories based on the population they were used for: ER-positive breast cancer (ER+), TNBC or basal breast cancer (TNBC), HER2-positive breast cancer (HER2+), un-classified breast cancer patients (uc-BC) or mixed types. The gene discussed is ERBB2; the disease is breast cancer.